LumiEso 스텐트 식도 시스템

생체 적합성 재료로 설계된 이 고급 스텐트 시스템은 다음을 제공합니다. 효과적인 지원 에 대한 식도 협착지속적인 내강 개통성 개선 삼키는 기능 다음과 같은 환자에서 식도 폐쇄.

LumiEso 스텐트 식도 시스템혁신적, 자체 확장 stent solution engineered to reestablish 그리고 maintain esophageal patency in patients with malignant 또는 benign strictures. Crafted with 고급 nitinol or hybrid alloys and featuring precision deployment mechanics, LumiEso stents foster 신뢰성 decompression under endoscopic 또는 fluoroscopic guidance—promoting 개선됨 ingestion, quality of life, and 감소 procedure times in everyday clinical practice.

주요 기능 및 기술

High-Radial-Force Stent Construction
  • Durable Nitinol/Hybrid Alloy: Supplies 연속 radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.
  • Durable Nitinol/Hybrid Alloy: Supplies 연속 radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.

Clinical Applications & Benefits

Malignant & Benign Strictures
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.